Page last updated: 2024-10-24

cetirizine and Cutaneous Mastocytosis

cetirizine has been researched along with Cutaneous Mastocytosis in 2 studies

Cetirizine: A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects.
cetirizine : A member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Kumar, A1
Kansal, NK1
Anuragi, RP1
Mann, C1
Sepp, N1
Simma, B1

Other Studies

2 other studies available for cetirizine and Cutaneous Mastocytosis

ArticleYear
Cutaneous mastocytosis: clinical, dermoscopic and pathological features.
    BMJ case reports, 2020, Dec-09, Volume: 13, Issue:12

    Topics: Cetirizine; Histamine H1 Antagonists, Non-Sedating; Humans; Infant; Male; Mastocytosis, Cutaneous

2020
Congenital cutaneous mastocytosis.
    The Journal of pediatrics, 2004, Volume: 145, Issue:1

    Topics: Cetirizine; Flushing; Histamine H1 Antagonists, Non-Sedating; Histamine H2 Antagonists; Humans; Infa

2004